Sarcopenia: European consensus on definition and diagnosis
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 80 of the 80 references it cites were found in a registry or an index.
Abstract
The European Working Group on Sarcopenia in Older People (EWGSOP) developed a practical clinical definition and consensus diagnostic criteria for age-related sarcopenia. EWGSOP included representatives from four participant organisations, i.e. the European Geriatric Medicine Society, the European Society for Clinical Nutrition and Metabolism, the International Association of Gerontology and Geriatrics—European Region and the International Association of Nutrition and Aging. These organisations endorsed the findings in the final document. The group met and addressed the following questions, using the medical literature to build evidence-based answers: (i) What is sarcopenia? (ii) What parameters define sarcopenia? (iii) What variables reflect these parameters, and what measurement tools and cut-off points can be used? (iv) How does sarcopenia relate to cachexia, frailty and sarcopenic obesity? For the diagnosis of sarcopenia, EWGSOP recommends using the presence of both low muscle mass + low muscle function (strength or performance). EWGSOP variously applies these characteristics to further define conceptual stages as ‘presarcopenia’, ‘sarcopenia’ and ‘severe sarcopenia’. EWGSOP reviewed a wide range of tools that can be used to measure the specific variables of muscle mass, muscle strength and physical performance. Our paper summarises currently available data defining sarcopenia cut-off points by age and gender; suggests an algorithm for sarcopenia case finding in older individuals based on measurements of gait speed, grip strength and muscle mass; and presents a list of suggested primary and secondary outcome domains for research. Once an operational definition of sarcopenia is adopted and included in the mainstream of comprehensive geriatric assessment, the next steps are to define the natural course of sarcopenia and to develop and define effective treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The European Working Group for the Study of Sarcopenia (EWGSOP)156 identified sarcopenia cut-off points and tools for its measurement. They recognized the lack of diagnostic criteria for sarcopenia but integrated low muscle mass and function (strength or performance) in their terminology, believing that the relationship between these two measures is not linear nor bidirectional73,156,181.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [156]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This algorithm was meant for clinical application using gait speed (<0.8 m/s) before muscle mass or strength measurement.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [156]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Also, the cut-off points for the Asian populations [9] are lower than for the non-Asian individuals [7] in both genders, with young people of the same ethnic group as reference.”
From Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies (2017) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to the amount of skeletal muscle, other conditions also affect functional outcomes: muscle quality, total body fat, neurologic function, cardiovascular and pulmonary function, and other comorbid conditions.16,208”
From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In older people, loss of muscle strength is associated with reduced functional capacity and increased health care costs.16”
From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [16]
Experimental — accuracy not yet measured
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907 · cited 3×
“Men: Based on quartiles of study group (n = 5,317) [27]”
BackgroundGuralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792 · cited 1×
“The SPPB evaluates balance, gait, strength and endurance by examining an individual’s ability to stand with the feet together in side-by-side, semi-tandem and tandem positions, time to walk 8 ft and time to rise from a chair and return to the seated position five times [58].”
BackgroundEpidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 13×
“The re- searchers concluded that BIA was a clinically relevant measure muscle function, which would be particularly useful for patients unable or unwilling to perform grip strength tests.”
BackgroundMethodInfluentialPrado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238 · cited 1×
“In conditions such as malignancy, rheumatoid arthritis and ageing, lean bodymass is lost while fat mass may be preserved or even increased [28].”
BackgroundJanssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139 · cited 2×
“[67] also used standard deviations to define sarcopenia, measured in terms of skeletal muscle index (SMI), where SMI = (skeletal muscle mass/ body mass) × 100.”
BackgroundMethodGoodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083 · cited 3×
“Intramuscular and visceral fat increase with ageing while subcutaneous fat declines [18, 32, 33].”
BackgroundGuralnik, J. M., Ferrucci, L., Pieper, C. F., Leveille, S. G., Markides, K. S., Ostir, G. V., Studenski, S., Berkman, L. F., & Wallace, R. B. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.4.m221 · Cited by 2,898 · cited 2×
“suggested that timed usual gait provides a predictive value for the onset of disability [62].”
BackgroundMeaningful change and responsiveness in common physical performance measures in older adults.
Perera, S., Mody, S. H., Woodman, R. C., & Studenski, S. A. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00701.x · Cited by 2,513 · cited 1×
“Meaningful changes in the SPPB have been defined [59, 60].”
BackgroundEvans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,450 · cited 2×
“Sarcopenia is one of the elements of the proposed definition for cachexia [22].”
BackgroundSarcopenia: origins and clinical relevance
Rosenberg, I. H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.990s · Cited by 2,399 · cited 1×
“In 1989, Irwin Rosenberg proposed the term ‘sarcopenia’ (Greek ‘sarx’ or flesh + ‘penia’ or loss) to describe this age-related decrease of muscle mass [1, 2].”
Background
Research works printed but not linked: 1
- Abellan van Kan, 2009, Gait speed as a marker of adverse outcomes, 881
Cited by
Items 1,101–1,200 of 1,247
Huang, R.-Y., Yang, K.-C., Chang, H.-H., Lee, L.-T., Lu, C.-W., & Huang, K.-C. (2016) · Nutrients · doi:10.3390/nu8060373 · Cited by 66
Arrieta, H., Hervás, G., Rezola-Pardo, C., Ruiz-Litago, F., Iturburu, M., Yanguas, J. J., Gil, S. M., Rodriguez-Larrad, A., & Irazusta, J. (2019) · Gerontology · doi:10.1159/000494137 · Cited by 66
Martínez-Amat, A., Aibar-Almazán, A., Fábrega-Cuadros, R., Cruz-Díaz, D., Jiménez-García, J. D., Pérez-López, F. R., Achalandabaso, A., Barranco-Zafra, R., & Hita-Contreras, F. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.02.005 · Cited by 65
Scott, D., Cumming, R., Naganathan, V., Blyth, F., Le Couteur, D. G., Handelsman, D. J., Seibel, M., Waite, L. M., & Hirani, V. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.04.006 · Cited by 65
“A recent study in Brazilian older adults used hand grip strength and waist circumference measurements to define sarcopenic obesity and reported odds for MetS that were 10- and 12-fold higher for obesity and sarcopenic obesity compared with controls (Cruz-Jentoft et al., 2010).”
InfluentialSanada, K., Chen, R., Willcox, B., Ohara, T., Wen, A., Takenaka, C., & Masaki, K. (2018) · Nutrition · doi:10.1016/j.nut.2017.09.003 · Cited by 65
Association of thyroid function with sarcopenia in elderly Chinese euthyroid subjects
Sheng, Y., Ma, D., Zhou, Q., Wang, L., Sun, M., Wang, S., Qi, H., Liu, J., Ding, G., & Duan, Y. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-018-1057-z · Cited by 65
Bone health assessment in older people with or without muscle health impairment
Locquet, M., Beaudart, C., Bruyère, O., Kanis, J. A., Delandsheere, L., & Reginster, J.-Y. (2018) · Osteoporosis International · doi:10.1007/s00198-018-4384-1 · Cited by 65
Jenkins, N. D. M., Buckner, S. L., Bergstrom, H. C., Cochrane, K. C., Goldsmith, J. A., Housh, T. J., Johnson, G. O., Schmidt, R. J., & Cramer, J. T. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.07.007 · Cited by 65
“Handgrip strength is commonly used as a surrogate for functionality andmuscle strength (DenOuden et al., 2011) in older adults and to classify sarcopenia in clinical practice (Cruz-Jentoft et al., 2010).”
Insulin Treatment Attenuates Decline of Muscle Mass in Japanese Patients with Type 2 Diabetes
Bouchi, R., Fukuda, T., Takeuchi, T., Nakano, Y., Murakami, M., Minami, I., Izumiyama, H., Hashimoto, K., Yoshimoto, T., & Ogawa, Y. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0251-x · Cited by 64
Dynapenic Obesity and Lower Extremity Function in Elderly Adults
Yang, M., Jiang, J., Hao, Q., Luo, L., & Dong, B. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.06.019 · Cited by 61
Ely, I. A., Phillips, B. E., Smith, K., Wilkinson, D. J., Piasecki, M., Breen, L., Larsen, M. S., & Atherton, P. J. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.08.010 · Cited by 64
Assessment and definition of lean body mass deficiency in the elderly
Müller, M. J., Geisler, C., Pourhassan, M., Glüer, C.-C., & Bosy-Westphal, A. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.169 · Cited by 63
Schoufour, J. D., Tieland, M., Barazzoni, R., Ben Allouch, S., Bie, J. V. D., Boirie, Y., Cruz-Jentoft, A. J., Eglseer, D., Topinková, E., Visser, B., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.661449 · Cited by 62
Self-citationvon Berens, Å., Obling, S. R., Nydahl, M., Koochek, A., Lissner, L., Skoog, I., Frändin, K., Skoglund, E., Rothenberg, E., & Cederholm, T. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01578-9 · Cited by 62
Self-citationEffects of progressive elastic band resistance exercise for aged osteosarcopenic adiposity women
Lee, Y.-H., Lee, P.-H., Lin, L.-F., Liao, C.-D., Liou, T.-H., & Huang, S.-W. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111272 · Cited by 62
Watanabe, K., Kouzaki, M., Ogawa, M., Akima, H., & Moritani, T. (2018) · European Review of Aging and Physical Activity · doi:10.1186/s11556-018-0192-z · Cited by 61
Relationship between major dietary patterns and sarcopenia among menopausal women
Mohseni, R., Aliakbar, S., Abdollahi, A., Yekaninejad, M. S., Maghbooli, Z., & Mirzaei, K. (2017) · Aging Clinical and Experimental Research · doi:10.1007/s40520-016-0721-4 · Cited by 59
Hulst, J. M., Huysentruyt, K., Gerasimidis, K., Shamir, R., Koletzko, B., Chourdakis, M., Fewtrell, M., Joosten, K. F., & Special Interest Group Clinical Malnutrition of ESPGHAN (2022) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003437 · Cited by 59
Yu, S., Powell, A., Khow, K., & Visvanathan, R. (2016) · Nutrients · doi:10.3390/nu8040189 · Cited by 58
“Ageing is often associated with a progressive decline in both weight and skeletal muscle mass and an increase in body fat [1].”
BackgroundMartin-Cantero, A., Reijnierse, E. M., Gill, B. M. T., & Maier, A. B. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuaa064 · Cited by 58
“The results showed that AAs, CR, HMB, and protein plus AA interventions had a positive effect on muscle mass measures, one of the diagnostic measures of sarcopenia according to the European Working Group on Sarcopenia in Older People definition.(4,92) Current definitions of sarcopenia also include muscle strength and…”
Zhang, X., Trevino, M. B., Wang, M., Gardell, S. J., Ayala, J. E., Han, X., Kelly, D. P., Goodpaster, B. H., Vega, R. B., & Coen, P. M. (2018) · The Journals of Gerontology: Series A · doi:10.1093/gerona/gly051 · Cited by 58
Marzetti, E., Calvani, R., Lorenzi, M., Tanganelli, F., Picca, A., Bossola, M., Menghi, A., Bernabei, R., & Landi, F. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.04.003 · Cited by 58
Self-citationThe prevalence of sarcopenia and related factors in a community-dwelling elders Thai population
Khongsri, N., Tongsuntud, S., Limampai, P., & Kuptniratsaikul, V. (2016) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2016.05.001 · Cited by 58
The dark side of Tregs during aging
Palatella, M., Guillaume, S. M., Linterman, M. A., & Huehn, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940705 · Cited by 58
Sarcopenia and polypharmacy among older adults: A scoping review of the literature
Pana, A., Sourtzi, P., Kalokairinou, A., & Velonaki, V. S. (2022) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2021.104520 · Cited by 57
Van Aller, C., Lara, J., Stephan, B. C. M., Donini, L. M., Heymsfield, S., Katzmarzyk, P. T., Wells, J. C. K., Prado, C. M., & Siervo, M. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.01.022 · Cited by 56
“A potential limitation of our approach to identify SO cases is that it is based on the assessment of muscle mass without taking into considerationmeasures of muscular function as recommended in recent guidelines [47,48].”
MethodDirks, M. L., Tieland, M., Verdijk, L. B., Losen, M., Nilwik, R., Mensink, M., de Groot, L. C. P. G. M., & van Loon, L. J. C. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.02.006 · Cited by 56
Ida, S., Nakai, M., Ito, S., Ishihara, Y., Imataka, K., Uchida, A., Monguchi, K., Kaneko, R., Fujiwara, R., Takahashi, H., et al. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.06.012 · Cited by 55
Low muscle mass in older men: The role of lifestyle, diet and cardiovascular risk factors
Atkins, J. L., Whincup, P. H., Morris, R. W., & Wannamethee, S. G. (2014) · The Journal of nutrition, health and aging · doi:10.1007/s12603-013-0336-9 · Cited by 55
“A standard statistical approach was used to define low muscle mass (participants below the first quartile of the distribution of MAMc or FFMi) since no consensus definition of sarcopenia has yet been adopted (7).”
InfluentialImpact of Cortisol on Reduction in Muscle Strength and Mass: A Mendelian Randomization Study
Katsuhara, S., Yokomoto-Umakoshi, M., Umakoshi, H., Matsuda, Y., Iwahashi, N., Kaneko, H., Ogata, M., Fukumoto, T., Terada, E., Sakamoto, R., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab862 · Cited by 55
Moon, J. H., Kim, K. M., Kim, J. H., Moon, J. H., Choi, S. H., Lim, S., Lim, J.-Y., Kim, K. W., Park, K. S., & Jang, H. C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166344 · Cited by 54
Shimizu, A., Maeda, K., Tanaka, K., Ogawa, M., & Kayashita, J. (2018) · Geriatrics & Gerontology International · doi:10.1111/ggi.13233 · Cited by 55
Petermann-Rocha, F., Ho, F. K., Welsh, P., Mackay, D., Brown, R., Gill, J. M. R., Sattar, N., Gray, S. R., Pell, J. P., & Celis-Morales, C. A. (2020) · Maturitas · doi:10.1016/j.maturitas.2020.04.017 · Cited by 52
“As detailed previously, there are many diagnostic criteria used to define sarcopenia [11-13].”
BackgroundLandi, F., Marzetti, E., Liperoti, R., Pahor, M., Russo, A., Martone, A. M., Colloca, G., Capoluongo, E., & Bernabei, R. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.04.012 · Cited by 54
Self-citationTrabal, J., Forga, M., Leyes, P., Torres, F., Rubio, J., Prieto, E., & Farran-Codina, A. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s75271 · Cited by 54
Protein metabolism in women and men: Similarities and disparities
Markofski, M. M., & Volpi, E. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3283412343 · Cited by 54
Endothelial function and the regulation of muscle protein anabolism in older adults
Timmerman, K. L., & Volpi, E. (2013) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.03.013 · Cited by 53
Association between sarcopenia and atherosclerosis in elderly patients with ischemic heart disease
Uchida, S., Kamiya, K., Hamazaki, N., Matsuzawa, R., Nozaki, K., Ichikawa, T., Suzuki, Y., Nakamura, T., Yamashita, M., Kariya, H., et al. (2020) · Heart and Vessels · doi:10.1007/s00380-020-01554-8 · Cited by 52
Rangel Peniche, D. B., Raya Giorguli, G., & Alemán-Mateo, H. (2015) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2015.03.007 · Cited by 50
Jung, H. N., Kim, S.-O., Jung, C. H., Lee, W. J., Kim, M. J., & Cho, Y. K. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06796-9 · Cited by 51
Moore, D. R., Kelly, R. P., Devries, M. C., Churchward‐Venne, T. A., Phillips, S. M., Parise, G., & Johnston, A. P. (2018) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12306 · Cited by 50
Kob, R., Fellner, C., Bertsch, T., Wittmann, A., Mishura, D., Sieber, C. C., Fischer, B. E., Stroszczynski, C., & Bollheimer, C. L. (2015) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12019 · Cited by 48
“mass and strength and/or function has been classified as a distinct clinical phenotype referred to as sarcopenia.(1) The cause of sarcopenia is multi-factorial and is therefore hard to discern, because many affected patients exhibit several of these morbidities at the same time.”
BackgroundHertfordshire sarcopenia study: design and methods
Patel, H. P., Syddall, H. E., Martin, H. J., Stewart, C. E., Cooper, C., & Sayer, A. A. (2010) · BMC Geriatrics · doi:10.1186/1471-2318-10-43 · Cited by 48
Kemmler, W., von Stengel, S., Engelke, K., Sieber, C., & Freiberger, E. (2016) · Osteoporosis International · doi:10.1007/s00198-015-3303-y · Cited by 47
Weight Loss Strategies in the Elderly: A Clinical Conundrum
Coker, R. H., & Wolfe, R. R. (2018) · Obesity · doi:10.1002/oby.21961 · Cited by 47
“The diagnosis of sarcopenia requires documentation of low muscle mass and one of the two additional criteria: (a) low muscle strength or (b) low physical performance (16).”
BackgroundThe role of muscle ultrasound to predict sarcopenia
Ozturk, Y., Koca, M., Burkuk, S., Unsal, P., Dikmeer, A., Oytun, M. G., Bas, A. O., Kahyaoglu, Z., Deniz, O., Coteli, S., et al. (2022) · Nutrition · doi:10.1016/j.nut.2022.111692 · Cited by 47
Kreidieh, D., Itani, L., El Masri, D., Tannir, H., Citarella, R., & El Ghoch, M. (2018) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd5040051 · Cited by 46
Power Versus Sarcopenia: Associations with Functionality and Physical Performance Measures
Bahat, G., Kilic, C., Eris, S., & Karan, M. A. (2021) · The Journal of nutrition, health and aging · doi:10.1007/s12603-020-1544-8 · Cited by 45
Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions
Wang, T., Zhou, D., & Hong, Z. (2025) · MedComm · doi:10.1002/mco2.70030 · Cited by 46
Kim, B.-J., Ahn, S. H., Lee, S. H., Hong, S., Hamrick, M. W., Isales, C. M., & Koh, J.-M. (2019) · Aging · doi:10.18632/aging.102068 · Cited by 42
Sayed, R. K. A., Fernández-Ortiz, M., Diaz-Casado, M. E., Rusanova, I., Rahim, I., Escames, G., López, L. C., Mokhtar, D. M., & Acuña-Castroviejo, D. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly059 · Cited by 45
Keogh, J. W., Grigg, J., & Vertullo, C. J. (2018) · PeerJ · doi:10.7717/peerj.4738 · Cited by 45
Hayhoe, R. P. G., Lentjes, M. A. H., Mulligan, A. A., Luben, R. N., Khaw, K.-T., & Welch, A. A. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.01.014 · Cited by 44
Nakamura, S., Sato, Y., Kobayashi, T., Kaneko, Y., Ito, E., Soma, T., Okada, H., Miyamoto, K., Oya, A., Matsumoto, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-69021-y · Cited by 44
Kawai, H., Kera, T., Hirayama, R., Hirano, H., Fujiwara, Y., Ihara, K., Kojima, M., & Obuchi, S. (2018) · Aging Clinical and Experimental Research · doi:10.1007/s40520-017-0781-0 · Cited by 44
Li, C.-Y., Fang, A.-P., Ma, W.-J., Wu, S.-L., Li, C.-L., Chen, Y.-M., & Zhu, H.-L. (2019) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2019.03.010 · Cited by 44
“A GING IS ACCOMPANIED BY A PROGRESSIVE DECLINE in skeletal muscle mass, which in severe cases may result in decreased muscle strength and impaired physical performance (ie, sarcopenia).(1) Low muscle mass (LMM) is strongly linked with fall, fracture, and frailty, which may lead to a loss of mobility and independence.”
BackgroundFairman, C. M., Kendall, K. L., Hart, N. H., Taaffe, D. R., Galvão, D. A., & Newton, R. U. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.11.003 · Cited by 43
Exercise-induced AMPK activation is involved in delay of skeletal muscle senescence
Yoon, K. J., Zhang, D., Kim, S.-J., Lee, M.-C., & Moon, H. Y. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.086 · Cited by 44
Shoemaker, M. E., Pereira, S. L., Mustad, V. A., Gillen, Z. M., McKay, B. D., Lopez‐Pedrosa, J. M., Rueda, R., & Cramer, J. T. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12932 · Cited by 43
Aarden, J. J., Reijnierse, E. M., van der Schaaf, M., van der Esch, M., Reichardt, L. A., van Seben, R., Bosch, J. A., Twisk, J. W. R., Maier, A. B., Engelbert, R. H. H., et al. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.12.006 · Cited by 43
Inflammation and metabolism: the role of adiposity in sarcopenic obesity
Lynch, G. M., Murphy, C. H., Castro, E. D. M., & Roche, H. M. (2020) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120007119 · Cited by 41
Zanker, J., Patel, S., Blackwell, T., Duchowny, K., Brennan-Olsen, S., Cummings, S. R., Evans, W. J., Orwoll, E. S., Scott, D., Vogrin, S., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.03.017 · Cited by 40
Juby, A. G., & Mager, D. R. (2019) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.04.003 · Cited by 40
Peng, T.-C., Chen, W.-L., Chen, Y.-Y., Chao, Y.-P., Wu, L.-W., & Kao, T.-W. (2021) · British Journal of Nutrition · doi:10.1017/s0007114521001288 · Cited by 35
“Sarcopenia was defined as low skeletal muscle mass index with either lowhandgrip strength or low gait speed or both, according to the consensus of the EuropeanWorking Group on Sarcopenia in Older People (EWGSOP) in 2010(21) The cut-off values of low skeletal muscle mass index, low handgrip strength and low gait speed…”
MethodPark, J. E., Lee, S., & Kim, K. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-03748-x · Cited by 39
Jeon, K. C., Kim, S.-Y., Jiang, F. L., Chung, S., Ambegaonkar, J. P., Park, J.-H., Kim, Y.-J., & Kim, C.-H. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17165847 · Cited by 38
Diet quality and osteosarcopenic obesity in community-dwelling adults 50 years and older
Kim, J., Lee, Y., Kye, S., Chung, Y.-S., Kim, J.-H., Chon, D., & Lee, K. E. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.08.007 · Cited by 37
Tabibi, H., As'habi, A., Najafi, I., & Hedayati, M. (2018) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.18.0064 · Cited by 37
“Skeletal muscle mass index (SMI) was calculated as the ratio of SMM in kilograms to the square of body height in meters (SMI = SMM/height(2)) [4,16,17].”
BackgroundMethodInfluentialAdams, V. J., Watson, P., Carmichael, S., Gerry, S., Penell, J., & Morgan, D. M. (2015) · Acta Veterinaria Scandinavica · doi:10.1186/s13028-016-0206-7 · Cited by 36
Steroid myopathy in patients with chronic respiratory diseases
Levin, O. S., Polunina, A. G., Demyanova, M. A., & Isaev, F. V. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.12.023 · Cited by 35
The Role of Exercise in Cancer-Related Sarcopenia and Sarcopenic Obesity
Papadopetraki, A., Giannopoulos, A., Maridaki, M., Zagouri, F., Droufakou, S., Koutsilieris, M., & Philippou, A. (2023) · Cancers · doi:10.3390/cancers15245856 · Cited by 34
“The term “sarcopenia” describes a syndrome characterised by the loss of skeletal muscle mass and strength and is derived from the Greek words “sarx” and “penia”, which mean “flesh” and “loss” [19].”
BackgroundMethodInfluentialCamajani, E., Persichetti, A., Watanabe, M., Contini, S., Vari, M., Di Bernardo, S., Faro, M., Lubrano, C., Gnessi, L., Caprio, M., et al. (2022) · Nutrients · doi:10.3390/nu14091884 · Cited by 34
“The sum of the scores provided a composite score ranging from 0 to 12; physical performance was considered impaired when the total SPPB score was ≤8 [1,2].”
BackgroundJo, Y., Linton, J. A., Choi, J., Moon, J., Kim, J., Lee, J., & Oh, S. (2019) · Korean Journal of Family Medicine · doi:10.4082/kjfm.17.0078 · Cited by 33
“, and (2) ASM divided by body weight (%), as proposed by Janssen et al.”
MethodGrönstedt, H., Vikström, S., Cederholm, T., Franzén, E., Luiking, Y. C., Seiger, Å., Wimo, A., Faxén-Irving, G., & Boström, A.-M. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.03.030 · Cited by 33
Self-citationNonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity
Wijarnpreecha, K., Panjawatanan, P., Aby, E., Ahmed, A., & Kim, D. (2019) · Maturitas · doi:10.1016/j.maturitas.2019.03.016 · Cited by 32
Strotmeyer, E. S., Winger, M. E., Cauley, J. A., Boudreau, R. M., Cusick, D., Collins, R. F., Chalhoub, D., Buehring, B., Orwoll, E., Harris, T. B., et al. (2018) · The Journal of nutrition, health and aging · doi:10.1007/s12603-018-1081-x · Cited by 32
A neurogenic perspective of Sarcopenia: time course study of sciatic nerves from aging mice
Krishnan, V. S., White, Z., McMahon, C. D., Hodgetts, S. I., Fitzgerald, M., Shavlakadze, T., Harvey, A. R., & Grounds, M. D. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw019 · Cited by 32
Sarcopenia, frailty circle and treatment with sodium–glucose cotransporter 2 inhibitors
Sasaki, T. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.12966 · Cited by 31
DiMaria-Ghalili, R. A., Sullivan-Marx, E. M., & Compher, C. (2014) · Biological Research For Nursing · doi:10.1177/1099800413503489 · Cited by 31
Xu, H.-Q., Liu, J.-M., Zhang, X., Xue, Y.-T., Shi, J.-P., Chen, W., & Zheng, X.-Y. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2020.10.021 · Cited by 28
Cheah, K. J., & Cheah, L. J. (2023) · Nutrition Journal · doi:10.1186/s12937-023-00880-7 · Cited by 29
Nonalcoholic fatty liver disease and sarcopenia: Where do we stand?
Mikolasevic, I., Pavic, T., Filipec Kanizaj, T., Bender, D. V., Domislovic, V., & Krznaric, Z. (2020) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2020/8859719 · Cited by 30
“Obesity aggravates sarcopenia, impairs physical performance, and increases mortality rates [12].”
BackgroundMethodInfluentialSarcopenia definitions and their association with fracture risk in older Swedish women
Gandham, A., Gregori, G., Johansson, L., Johansson, H., Harvey, N. C., Vandenput, L., McCloskey, E., Kanis, J. A., Litsne, H., Axelsson, K., et al. (2024) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjae026 · Cited by 29
Additive effect of low skeletal muscle mass and abdominal obesity on coronary artery calcification
Jun, J. E., Kang, M., Jin, S.-M., Kim, K., Hwang, Y.-C., Jeong, I.-K., & Kim, J. H. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-0885 · Cited by 27
Liu, L.-K., Chen, L.-Y., Yeh, K.-P., Lin, M.-H., Hwang, A.-C., Peng, L.-N., & Chen, L.-K. (2014) · Journal of Clinical Gerontology and Geriatrics · doi:10.1016/j.jcgg.2014.01.002 · Cited by 26
The Health-Promoting Effects and the Mechanism of Intermittent Fasting
Liu, S., Zeng, M., Wan, W., Huang, M., Li, X., Xie, Z., Wang, S., & Cai, Y. (2023) · Journal of Diabetes Research · doi:10.1155/2023/4038546 · Cited by 27
Chang, W.-T., Wu, C.-H., Hsu, L.-W., Chen, P.-W., Yu, J.-R., Chang, C.-S., Tsai, W.-C., & Liu, P.-Y. (2017) · Scientific Reports · doi:10.1038/srep40996 · Cited by 27
Sousa-Santos, A. R., Afonso, C., Borges, N., Santos, A., Padrão, P., Moreira, P., & F Amaral, T. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-033661 · Cited by 27
Can artificial intelligence simplify the screening of muscle mass loss?
Buccheri, E., Dell’Aquila, D., Russo, M., Chiaramonte, R., Musumeci, G., & Vecchio, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16323 · Cited by 27
“Sarcopenia, in particular, represents a frequent pathology characterized by the contemporary presence of the loss of muscle mass, called pre-sarcopenia [2], and loss of muscle strength with a possible reduction of motor performance [1,3].”
BackgroundDeng, F., Wu, W., Fan, X., Zhong, X., Wang, N., Wang, Y., Pan, T., & Du, Y. (2023) · International Journal of Endocrinology · doi:10.1155/2023/9926462 · Cited by 26
Ran, S., Jiang, Z.-X., He, X., Liu, Y., Zhang, Y.-X., Zhang, L., Pei, Y.-F., Zhang, M., Hai, R., Gu, G.-S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-61406-3 · Cited by 26
Branched-Chain Amino Acid Supplementation Ameliorates Angiotensin II-Induced Skeletal Muscle Atrophy
Yamanashi, K., Kinugawa, S., Fukushima, A., Kakutani, N., Takada, S., Obata, Y., Nakano, I., Yokota, T., Kitaura, Y., Shimomura, Y., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117593 · Cited by 25
Nutrition for Older Athletes: Focus on Sex-Differences
Strasser, B., Pesta, D., Rittweger, J., Burtscher, J., & Burtscher, M. (2021) · Nutrients · doi:10.3390/nu13051409 · Cited by 25
“Intriguingly, in a cross-sectional study including 156 female and male masters athletes aged between 40–79 years, no individual was categorized as sarcopenic, i.e., below normal levels of muscle mass and muscle strength or performance, according to the definition of the European Working Group for Sarcopenia in Older P…”
BackgroundSarcopenia and Health Care Utilization in Older Women
Cawthon, P. M., Lui, L.-Y., McCulloch, C. E., Cauley, J. A., Paudel, M. L., Taylor, B., Schousboe, J. T., & Ensrud, K. E. (2017) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw118 · Cited by 24
Patel, H. P., Dawson, A., Westbury, L. D., Hasnaoui, G., Syddall, H. E., Shaw, S., Sayer, A. A., Cooper, C., & Dennison, E. M. (2018) · Calcified Tissue International · doi:10.1007/s00223-018-0388-2 · Cited by 24
New Molecular Targets and Lifestyle Interventions to Delay Aging Sarcopenia
Sanchis-Gomar, F., Pareja-Galeano, H., Mayero, S., Perez-Quilis, C., & Lucia, A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00156 · Cited by 24
Pathophysiological analyses of skeletal muscle in obese type 2 diabetes SDT fatty rats
Kemmochi, Y., Ohta, T., Motohashi, Y., Kaneshige, A., Katsumi, S., Kakimoto, K., Yasui, Y., Anagawa-Nakamura, A., Toyoda, K., Taniai-Riya, E., et al. (2018) · Journal of Toxicologic Pathology · doi:10.1293/tox.2017-0064 · Cited by 23
Linking epidemiology and molecular mechanisms in sarcopenic obesity in populations
El Bizri, I., & Batsis, J. A. (2020) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120000075 · Cited by 23
Shen, Y., Liu, D., Li, S., He, Y., Tan, F., Sun, X., Li, D., Xia, X., & Hao, Q. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.811746 · Cited by 23
Chang, J. S., Kim, T. H., Kim, H., Choi, E. H., Kim, N., & Kong, I. D. (2017) · Geriatrics & Gerontology International · doi:10.1111/ggi.12681 · Cited by 21
Metadata
- Authors
- Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., Topinková, E., Vandewoude, M., & Zamboni, M.
- Affiliations
- Hospital Universitario Ramón y Cajal (ES)
- Damiaan Dicht bij het leven (BE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Clermont Université 4 , UFR Médecine, UMR 1019, F-63001 Clermont-Ferrand , France
- Uppsala University (SE)
- Università Cattolica del Sacro Cuore (IT)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- University Hospital of Geneva (CH)
- Hôpital de La Grave (FR)
- Centre Hospitalier Universitaire de Nice (FR)
- Charles University (CZ)
- University of Antwerp (BE)
- University of Verona (IT)
- Corresponding author
- Cruz-Jentoft, Alfonso J.
- ORCID
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-04-13
- Volume
- 39
- Issue
- 4
- Pages
- 412-423
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- PMC
- PMC2886201
- OpenAlex
- W2102902846
- Cited by
- 11,601
- References
- 80
- Citations by year
- 2026: 468 · 2025: 791 · 2024: 879 · 2023: 913 · 2022: 1031 · 2021: 1056 · 2020: 1131 · 2019: 1021 · 2018: 1059 · 2017: 811 · 2016: 685 · 2015: 591 · 2014: 494 · 2013: 290 · 2012: 207
- FWCI
- 142.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Age and Ageing (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- reroDoc Digital Library (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- European Geriatric Medicine Society
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- sarcopenia, older adults, diagnostic criteria, muscle mass, muscle strength, physical performance, walking speed, grip strength, sarcopenic obesity, frailty, cachexia, pre-sarcopenia, cut-off values, case-finding algorithms, comprehensive geriatric assessment
- MeSH terms
- Aged, Aged, 80 and over, Aging, Cachexia, Female, Humans, Male, Obesity, Geriatric Assessment, Frail Elderly, Muscle, Skeletal, Muscle Strength, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

